![Helene Martin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Helene Martin
Corporate Officer/Principal en The Walter & Eliza Hall Institute of Medical Research .
Cargos activos de Helene Martin
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
The Walter & Eliza Hall Institute of Medical Research
![]() The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Corporate Officer/Principal | - | - |
Historial de carrera de Helene Martin
Formación de Helene Martin.
University of Melbourne | Doctorate Degree |
RMIT University | Graduate Degree |
Estadísticas
Internacional
Australia | 4 |
Operativa
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
The Walter & Eliza Hall Institute of Medical Research
![]() The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Commercial Services |
- Bolsa de valores
- Insiders
- Helene Martin
- Experiencia